DocCheck AG(DE:AJ91)
€10.400.00 (0.00%)
DE:AJ91
DocCheck AG financials statements
€10.40
At close:0.00 (0.00%)
Want to see DE:AJ91 full AI Analyst Report?
DocCheck AG (AJ91) Ratios
3 Followers
DocCheck AG Ratios
DE:AJ91's free cash flow for Q2 2026 was €1.83M. For the 2026 fiscal year, DE:AJ91's free cash flow was decreased by €-1.64M and operating cash flow was €3.47M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 3.18 | 2.74 | 2.65 | 2.49 | 3.01 |
| Quick Ratio | 2.84 | 2.50 | 2.41 | 2.25 | 2.71 |
| Cash Ratio | 1.36 | 1.23 | 1.11 | 0.94 | 1.51 |
| Solvency Ratio | 0.58 | 0.37 | 0.39 | 0.38 | 0.63 |
| Operating Cash Flow Ratio | 0.58 | 0.57 | 0.58 | 0.42 | 0.91 |
| Short-Term Operating Cash Flow Coverage | 6.45 | 8.58 | 8.39 | 6.45 | 13.08 |
| Net Current Asset Value | € 19.85M | € 16.96M | € 16.35M | € 11.35M | € 14.23M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.07 | 0.08 | 0.10 | 0.11 | 0.12 |
| Debt-to-Equity Ratio | 0.10 | 0.12 | 0.16 | 0.18 | 0.19 |
| Debt-to-Capital Ratio | 0.09 | 0.11 | 0.14 | 0.15 | 0.16 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.34 | 1.52 | 1.50 | 1.64 | 1.61 |
| Debt Service Coverage Ratio | 5.41 | 7.18 | 6.97 | 4.87 | 13.55 |
| Interest Coverage Ratio | 18.49 | 34.00 | 27.96 | 8.61 | 68.30 |
| Debt to Market Cap | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 |
| Interest Debt Per Share | 0.90 | 1.02 | 1.18 | 1.65 | 1.45 |
| Net Debt to EBITDA | -0.99 | -1.18 | -0.91 | -0.47 | -0.56 |
| Profitability Margins | |||||
| Gross Profit Margin | 22.20% | 19.58% | 24.29% | 23.12% | 25.07% |
| EBIT Margin | 13.75% | 14.40% | 8.44% | 17.30% | 20.40% |
| EBITDA Margin | 18.78% | 18.93% | 17.57% | 21.98% | 23.38% |
| Operating Profit Margin | 13.75% | 12.02% | 6.63% | 17.09% | 19.39% |
| Pretax Profit Margin | 15.08% | 14.05% | 8.21% | 15.31% | 20.12% |
| Net Profit Margin | 9.64% | 9.82% | 4.25% | 10.33% | 13.27% |
| Continuous Operations Profit Margin | 9.64% | 9.82% | 3.99% | 10.30% | 13.76% |
| Net Income Per EBT | 63.93% | 69.91% | 51.83% | 67.46% | 65.97% |
| EBT Per EBIT | 109.68% | 116.88% | 123.72% | 89.57% | 103.77% |
| Return on Assets (ROA) | 9.58% | 8.68% | 4.05% | 9.94% | 18.93% |
| Return on Equity (ROE) | 12.82% | 13.18% | 6.08% | 16.31% | 30.56% |
| Return on Capital Employed (ROCE) | 16.90% | 13.74% | 8.21% | 21.20% | 34.57% |
| Return on Invested Capital (ROIC) | 10.58% | 9.25% | 3.83% | 13.75% | 22.86% |
| Return on Tangible Assets | 9.63% | 8.71% | 4.05% | 9.98% | 19.04% |
| Earnings Yield | 8.55% | 12.47% | 4.90% | 8.59% | 7.33% |
| Efficiency Ratios | |||||
| Receivables Turnover | 5.01 | 4.21 | 5.42 | 5.10 | 8.45 |
| Payables Turnover | 22.12 | 15.69 | 17.50 | 18.44 | 32.24 |
| Inventory Turnover | 11.93 | 13.08 | 12.59 | 13.98 | 17.69 |
| Fixed Asset Turnover | 4.05 | 3.75 | 3.38 | 3.17 | 5.92 |
| Asset Turnover | 0.99 | 0.88 | 0.95 | 0.96 | 1.43 |
| Working Capital Turnover Ratio | 2.34 | 2.37 | 2.51 | 2.69 | 3.85 |
| Cash Conversion Cycle | 86.94 | 91.29 | 75.43 | 77.91 | 52.50 |
| Days of Sales Outstanding | 72.84 | 86.65 | 67.30 | 71.60 | 43.19 |
| Days of Inventory Outstanding | 30.59 | 27.91 | 28.99 | 26.11 | 20.63 |
| Days of Payables Outstanding | 16.50 | 23.27 | 20.86 | 19.80 | 11.32 |
| Operating Cycle | 103.44 | 114.56 | 96.29 | 97.71 | 63.82 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 1.21 | 1.54 | 1.48 | 1.17 | 2.17 |
| Free Cash Flow Per Share | 0.52 | 1.34 | 1.11 | -0.11 | 1.37 |
| Dividend Paid and CapEx Coverage Ratio | 0.84 | 2.21 | 1.32 | 0.51 | 1.21 |
| Capital Expenditure Coverage Ratio | 1.74 | 7.84 | 3.97 | 0.91 | 2.72 |
| Operating Cash Flow Coverage Ratio | 1.48 | 1.56 | 1.28 | 0.83 | 1.55 |
| Operating Cash Flow to Sales Ratio | 0.11 | 0.15 | 0.14 | 0.10 | 0.13 |
| Free Cash Flow Yield | 4.19% | 16.09% | 12.12% | -0.76% | 4.44% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 11.71 | 8.02 | 20.41 | 11.64 | 13.64 |
| Price-to-Sales (P/S) Ratio | 1.13 | 0.79 | 0.87 | 1.20 | 1.81 |
| Price-to-Book (P/B) Ratio | 1.50 | 1.06 | 1.24 | 1.90 | 4.17 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 23.88 | 6.21 | 8.25 | -131.28 | 22.53 |
| Price-to-Operating Cash Flow Ratio | 10.16 | 5.42 | 6.17 | 12.44 | 14.24 |
| Price-to-Earnings Growth (PEG) Ratio | 12.18 | 0.06 | -0.32 | -0.26 | 0.57 |
| Enterprise Value Multiple | 5.01 | 2.98 | 4.03 | 5.00 | 7.19 |
| Enterprise Value | 52.09M | 30.35M | 37.85M | 66.93M | 144.37M |
| EV to EBITDA | 5.01 | 2.98 | 4.03 | 5.00 | 7.19 |
| EV to Sales | 0.94 | 0.56 | 0.71 | 1.10 | 1.68 |
| EV to Free Cash Flow | 19.93 | 4.45 | 6.73 | -119.97 | 20.91 |
| EV to Operating Cash Flow | 8.48 | 3.88 | 5.04 | 11.37 | 13.22 |
| Tangible Book Value Per Share | 8.14 | 7.86 | 7.48 | 7.78 | 7.51 |
| Shareholders’ Equity Per Share | 8.20 | 7.90 | 7.37 | 7.66 | 7.41 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.36 | 0.30 | 0.51 | 0.33 | 0.32 |
| Revenue Per Share | 10.90 | 10.60 | 10.54 | 12.10 | 17.07 |
| Net Income Per Share | 1.05 | 1.04 | 0.45 | 1.25 | 2.27 |
| Tax Burden | 0.64 | 0.70 | 0.52 | 0.67 | 0.66 |
| Interest Burden | 1.10 | 0.98 | 0.97 | 0.89 | 0.99 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.09 | 0.08 | 0.01 | 0.01 | 0.01 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.15 | 1.48 | 3.31 | 0.94 | 0.96 |
Currency in EUR
